Victoria Hospital, in London, Ontario, Canada, is a large teaching hospital affiliated with the University of Western Ontario. Along with University Hospital it is part of London Health Sciences Centre, which itself is the Lead Trauma Hospital of the Southwestern Local Health Integration Network.

There are 559 beds in Victoria Hospital.

During the past decade, Victoria Hospital conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 27 clinical trials were completed, i.e. on average, 38% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 23 clinical trials were completed. i.e. 115% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Victoria Hospital" #1 sponsor was "Lawson Health Research Institute" with 20 trials, followed by "Celgene" with 10 trials sponsored, "Takeda" with 7 trials sponsored, "Children's Oncology Group" with 6 trials sponsored and "Western University, Canada" with 6 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Victoria Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator and "Arch Biopartners Inc." with 1 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Victoria Hospital" are "Crohn's Disease" (8 trials), "Colitis, Ulcerative" (7 trials), "Ulcerative Colitis" (7 trials), "Crohn Disease" (6 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "Victoria Hospital" in a lesser frequency.

Most popular intervention types in "Victoria Hospital" are "Drug" (54 trials), "Other" (19 trials), "Biological" (10 trials), "Device" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Dexamethasone" (5 trials), "Methotrexate" (5 trials), "Cyclophosphamide" (4 trials) and "Doxorubicin Hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Victoria Hospital" are 76 trials for "All" genders, 10 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 31 active trials in "Victoria Hospital". 1 are not yet recruiting, 21 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 35 completed trials in Victoria Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Victoria Hospital, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 18 trials that are defined as “Not Applicable".